<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">35606923</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>24</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2326-5205</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>23</Day>
            </PubDate>
          </JournalIssue>
          <Title>Arthritis &amp; rheumatology (Hoboken, N.J.)</Title>
          <ISOAbbreviation>Arthritis Rheumatol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>In vivo generating SSA/Ro-antigen specific regulatory T cells improves experimental Sjögren's syndrome in mice.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/art.42244</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Sjögren's syndrome (SS) is a systemic autoimmune disease and T cells play an important role in the initiation and perpetuation of the disease. Here, we developed an immunotherapy for SS-like NOD/Ltj mice by combining a transient depletion of CD4<sup>+</sup> T cells together with the administration of autoantigen-specific peptide Ro480.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">NOD/Ltj mice were treated with single anti-CD4 mAb followed 2 days later by a series of 6 injections (i.p.) of Ro480-494 every other day. Salivary flow rates were determined pre- and post-treatment once a week. Mice were sacrificed 6 weeks post initial anti-CD4 mAb treatment, salivary glands (SG) were collected for analyses of histological disease scores and inflammatory cell infiltration, PCR determination of genes and flow cytometry analysis including MHC class II tetramer staining of immune cells. In addition, adoptive transferring of Tregs was administrated to investigate the function of the newly generating Treg in vivo.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">The combination of anti-CD4 mAb with autoantigen-specific peptide Ro480 generates SSA/Ro-antigen specific Tregs in vivo, which can suppress IFN-γ production of CD4<sup>+</sup> T cells and the inflammation infiltration in SG, and maintain the function of SG.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our findings provide a new approach to generating antigen-specific Tregs in vivo for SS treatment, which should have implications for potential therapy for patients with SS.</AbstractText>
          <CopyrightInformation>© 2022 American College of Rheumatology.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Xu</LastName>
            <ForeName>Junji</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Mucosal Immunology Section, NIDCR, NIH, Bethesda, MD, 20892, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Periodontology, School of Stomatology, Capital Medical University, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Ousheng</ForeName>
            <Initials>O</Initials>
            <AffiliationInfo>
              <Affiliation>Mucosal Immunology Section, NIDCR, NIH, Bethesda, MD, 20892, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Dandan</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Mucosal Immunology Section, NIDCR, NIH, Bethesda, MD, 20892, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Fu</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Mucosal Immunology Section, NIDCR, NIH, Bethesda, MD, 20892, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Dunfang</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Mucosal Immunology Section, NIDCR, NIH, Bethesda, MD, 20892, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jin</LastName>
            <ForeName>Wenwen</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Mucosal Immunology Section, NIDCR, NIH, Bethesda, MD, 20892, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cain</LastName>
            <ForeName>Alexander</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Mucosal Immunology Section, NIDCR, NIH, Bethesda, MD, 20892, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bynum</LastName>
            <ForeName>Andrew</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Mucosal Immunology Section, NIDCR, NIH, Bethesda, MD, 20892, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Na</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Mucosal Immunology Section, NIDCR, NIH, Bethesda, MD, 20892, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Han</LastName>
            <ForeName>Yichen</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Mucosal Immunology Section, NIDCR, NIH, Bethesda, MD, 20892, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>WanJun</ForeName>
            <Initials>W</Initials>
            <Identifier Source="ORCID">0000-0002-9335-2114</Identifier>
            <AffiliationInfo>
              <Affiliation>Mucosal Immunology Section, NIDCR, NIH, Bethesda, MD, 20892, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>23</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Arthritis Rheumatol</MedlineTA>
        <NlmUniqueID>101623795</NlmUniqueID>
        <ISSNLinking>2326-5191</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>24</Day>
          <Hour>0</Hour>
          <Minute>32</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>25</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>25</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35606923</ArticleId>
        <ArticleId IdType="doi">10.1002/art.42244</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
